Ipca Laboratories has announced the incorporation of a wholly-owned subsidiary, Ipca Pharmaceuticals GmbH, in the Federal Republic of Germany. The subsidiary has an initial paid-up capital of Euro € 25,000. The aim is to hold product registrations, participate in institutional business, and distribute generic formulations within Germany.
New German Subsidiary
Ipca Laboratories has established a wholly-owned subsidiary named “Ipca Pharmaceuticals GmbH” in the Federal Republic of Germany.
Subsidiary Details
The newly formed entity, Ipca Pharmaceuticals GmbH, has been set up with an initial paid-up capital of Euro € 25,000. The primary focus of the subsidiary will be to hold product registrations in Germany. It will participate in institutional business, as well as to undertake the distribution of generic formulations throughout the country.
Source: BSE